ABOUT BIKANTA
ABOUT BIKANTA
ABOUT BIKANTA
ABOUT BIKANTA
OUR MISSION
Our objective is to develop and bring to market the most advanced products for medical diagnostics and optical imaging to allow questions to be addressed at the molecular and cellular level. We commit ourselves to the highest standards of scientific rigor, ethics, innovation and generosity towards all. At the core of our effort is a collective determination to provide hope for a better life for patients facing difficult battles with debilitating diseases such as cancer.
core values
TEAM
Ambika Bumb
,
PhD
Ambika Bumb
,
PhD
Ambika Bumb
,
PhD
Ambika Bumb
,
PhD
Ambika Bumb
,
PhD
Find me on LinkedIn
Bikanta’s founder and CEO, Ambika Bumb graduated from Georgia Tech and obtained her doctorate from Oxford while on the prestigious Marshall Scholarship. She completed post-doctoral fellowships at the National Cancer Institute and National Heart Lung and Blood Institute where she developed Bikanta’s nanodiamond-based technologies. She has received numerous scholarships and awards for excellence in engineering and was profiled early in her career in Nature as a successful young scientist on the fast track. Her endeavors in the areas of nanomedicine and diagnostics have led to multiple patents and many publications.
Li Zhuo
,
PhD
Li Zhuo
,
PhD
Li Zhuo
,
PhD
Li Zhuo
,
PhD
Li Zhuo
,
PhD
Find me on LinkedIn
An accomplished product development professional, Li Zhuo has a long track record of new technology development in the fields of architectural coatings and medical diagnostics that he is now enthusiastically applying towards Bikanta’s innovations. Li started his focus on polymer colloids with early academic research and continued his graduate training in both surface chemistry and polymer engineering. After graduating from Lehigh University Emulsion Polymers Institute, he accumulated over 20 years of industrial experience in latex and nanoparticle synthesis, surface modification and characterization at BASF and Thermo Fisher Scientific.
Min Wang
,
PhD
Min Wang
,
PhD
Min Wang
,
PhD
Min Wang
,
PhD
Min Wang
,
PhD
Find me on LinkedIn
With 15 years of experience in biochemistry, microbiology, material science and nanotechnology, Min Wang joined the Bikanta team to accelerate nanodiamond technology development. She was previously a Senior Research Engineer at Pharmaco-Kinesis Corporation (PKC) working on point-of- care diagnostics and biosensor functionalization chemistry. Her training as a postdoc at UC Davis, as an American Heart Association fellow at UC Denver, and as a PhD student at Arizona State University is where she developed her expertise in bioconjugation, bioanalytical chemistry and assay development for diagnostics.
Joyce Wahba
,
Joyce Wahba
,
Joyce Wahba
,
Joyce Wahba
,
Joyce Wahba
,
Find me on LinkedIn
A Chemical Biology major at UC Berkeley who is passionate about medicine and finding practical solutions to current health epidemics, Joyce's interests are in synthesizing novel chemical tools to investigate biological systems. Her academic endeavors have included research on Multiple Sclerosis at Osaka University in Japan where she received 1st place in the program and studying stem cell differentiation into oligodendrocytes in the David Schaffer Lab. In her free time, Joyce enjoys volunteering with Habitat for Humanity, the American Red Cross, and Alta Bates Hospital.
Terry Sachlos
,
PhD
Terry Sachlos
,
PhD
Terry Sachlos
,
PhD
Terry Sachlos
,
PhD
Terry Sachlos
,
PhD
Find me on LinkedIn
A serial inventor with 8 patents, Oxford alumni Terry Sachlos previously co-founded TEOX Ltd which developed customizable bone grafts. As CSO of TEOX Terry was instrumental in winning the Oxford Business Competition and raising first-round funding for TEOX. He continued with postdocs at MIT, Harvard, and McMaster University. His findings have led to a clinical trial to repurpose thioridazine as an agent able to selectively target cancer stem cells present in acute myeloid leukemia (AML) patients.
Jesus Frias
,
Jesus Frias
,
Jesus Frias
,
Jesus Frias
,
Jesus Frias
,
Find me on LinkedIn
A recent graduate from the University at Albany in New York, Jesus has a Bachelor’s of Science in Biology. He was Paolo Forni’s lab where he studied the development of sensory neurons in the vomeronasal organ of mice. He also conducted research at the University of Massachusetts Medical School in the Darryl Bosco lab, where he helped in the development of nanobodies that bind to misfolded proteins involved in the pathogenesis of ALS. Jesus is passionate about research in developmental biology, neuroscience, and biochemistry and wants to use his passion for research in the field of medicine. A true good Samaritan, in his spare time he volunteered in ERs, senior community centers, and to tutor his fellow students.
board of advisors
Peter Dobson
,
PhD
Peter Dobson
,
PhD
Find me on LinkedIn
Bikanta’s Board of Advisors is being led by Professor Peter Dobson, Principal Fellow at University of Warwick’s Manufacturing Group. As Director of Oxford’s Begbroke Science Park from 2002-2013, he was involved in the initial stages of many (>25) start-up companies. He has himself spun-off multiple companies including Oxonica, Oxford Biosensors, and Oxford NanoSystems, published over 180 papers and 30 patents, and been the Strategic Advisor on Nanotechnology to the UK Research Councils.
Ileane Rosenthal
,
MBA
Ileane Rosenthal
,
MBA
Find me on LinkedIn
Harvard MBA and finance executive Ileane Rosenthal, has been the Co-Founder of the International Biomedical Research Alliance, President of Churchill Partners, and Executive Vice President of Securities Industry and Financial Markets Association (SIMFA). She brings strengths in strategic business development, client relationship management, marketing, funding, and program growth to Bikanta’s Board of Advisors.
William Annett
,
MBA
William Annett
,
MBA
Find me on LinkedIn
Five time CEO and currently that of Oncocyte, William Annett’s expansive diagnostics industry experience includes CEO at BioFX Laboratories (sold to a large life sciences company), founding and leading prenatal diagnostics Corra Life Sciences, and significant management positions at Genentech and Accenture. At Genentech, he led large operational projects with a $150 million budget and >400 team members and supported all development pipeline products and >200 clinical trials. As Managing Director at Accenture, he founded, built, and headed West Coast Life Sciences practice with sales, marketing, and delivery responsibilities for the entire territory.
Nalini Murdter
,
PhD, MBA
Nalini Murdter
,
PhD, MBA
Find me on LinkedIn
A 25 year veteran in biotech, Dr. Nalini Murdter has worked in the early stages to establish global businesses across life sciences and diagnostics markets. Currently Managing Director at JSR Micro, her previous roles have included Chief Business Officer at San Diego Blood Bank and NanoString Technologies and senior management positions at Agilent Technologies and Adeza Biomedical in Marketing, Acquisitions, Alliances, Venture, and Business Development. She is on the Board of Directors of the National Lymphedema Network, was previously an American Cancer Society Fellow, and a Senior Research Fellow at California Institute of Technology.
Dean Ho
,
PhD
Dean Ho
,
PhD
Find me on LinkedIn
Professor Dean Ho currently holds a position in the Division of Oral Biology and Medicine and Division of Advanced Prosthodontics, Biomaterials, and Hospital Dentistry while also being the Co-Director of the Center for Reconstructive Biotechnology at UCLA. Highly recognized with many awards and high impact publications, Dr. Ho’s research has been in nanomedicine and on the development of nanodiamond complexes for clinically translatable applications, particularly for cancer therapy and wound healing. He was previously an Associate Professor Northwestern University.
PARTNERS
Home